Tag: Broad Institute
-
Science & Tech
Think of them as utility players
New study shows that microglia cells “listen in” to neighboring neurons and change to match them.
-
Health
Large alcohol study challenges heart health claims
A large study challenges the theory that light alcohol consumption benefits heart health.
-
Science & Tech
Drug delivery system offers hope for treating genetic diseases
A team of researchers has developed a new drug delivery system that was able to edit genes associated with high cholesterol and to partially restore vision in mice.
-
Science & Tech
Taking a step toward discovering the cause of joint disease
A Harvard study could lead to potential therapeutics for one of the most prominent ailments of the elderly and one of the most prominent musculoskeletal defects in newborns.
-
Science & Tech
New gene-editing technique shows promise against sickle cell disease
Scientists at Harvard and the Broad Institute have demonstrated that it is possible to treat sickle cell disease in mice using a new gene-editing technique.
-
Campus & Community
Looking back on Harvard’s COVID response one year later
Health experts, leaders, and staff offered input, helped devise Harvard’s coronavirus policy and procedures.
-
Science & Tech
A ‘miracle poison’ for novel therapeutics
Researchers prove they can engineer proteins to find new targets with high selectivity, a critical advance toward potential new treatments to help neuroregeneration, cytokine storm.
-
Science & Tech
Growing the family tree
More than one-third of the U.S. population is made up of individuals with recent ancestors from multiple continents. A new genetics tool helps uncover disease-associated gene variants in these individuals.
-
Science & Tech
Innovative tool offers hope for children with rapid-aging disease
Several hundred children worldwide live with progeria, a deadly premature aging disease.
-
Health
At-home COVID testing launches in Boston
The TestBoston study will facilitate at-home testing on 10,000 people for both the SARS-CoV-2 virus and antibodies against it to increase access to testing and surveillance.
-
Health
‘Before a tsunami hits’
Seven researchers discuss the importance of COVID-19 research and pandemic preparedness, the value of teamwork, and the fragility of life.
-
Science & Tech
A promise to a friend
Wei Hsi “Ariel” Yeh dedicated her research in chemistry to solving some of the vast genetic mysteries behind hearing loss.
-
Health
Mapping the cancer connection
A new study takes the most comprehensive look to date at the connection between the ancestry and the molecular makeup of cancer.
-
Science & Tech
CRISPR-based technology spots COVID-19
The CRISPR-based molecular diagnostics chip’s capacity ranges from detecting a single type of virus in more than 1,000 samples at a time to searching a small number of samples for more than 160 different viruses, including the COVID-19 virus.
-
Science & Tech
Facing a pandemic, Broad does a quick pivot
Facing a pandemic, scientific and administrative teams across the Broad Institute raced to enable coronavirus testing in a matter of days.
-
Science & Tech
A crisper CRISPR
Fewer off-target edits and greater targeting scope bring gene editing technology closer to treating human diseases.
-
Campus & Community
Phi Beta Kappa ceremony honors 168 students
Eric Lander, president and founding director of the Broad Institute of MIT and Harvard, and poet Dan Chiasson, poetry critic for The New Yorker and a professor at Wellesley College, spoke before honored students and faculty at the 229th Phi Beta Kappa literary exercises at Sanders Theatre on Tuesday morning.
-
Science & Tech
Researchers ID molecules that rein in CRISPR systems
Scientists have identified the first chemical compounds able to inhibit and regulate CRISPR systems, which could ultimately make CRISPR gene-editing technologies more precise, efficient, and safe.
-
Health
Calculating genetic risk for obesity
A “polygenic score” for obesity, a quantitative tool that predicts an individual’s inherited risk for becoming overweight, may identify an opportunity for early intervention.
-
Health
Cystic fibrosis clues found in newly identified cell type
Researchers have found cells that appear to be the primary source of activity of the gene responsible for cystic fibrosis, a serious, multiorgan disease.
-
Campus & Community
Professor Paola Arlotta awarded George Ledlie Prize
Developmental neurobiologist Paola Arlotta has been awarded the George Ledlie Prize by the President and Fellows of Harvard College.
-
Science & Tech
Skin pigmentation is far more complex than thought
The genetics of skin pigmentation become progressively complex the closer populations reside to the equator.
-
Health
How a child made scientists think of cytokines as knobs instead of switches
A rare anemia is opening scientists up to a new way of thinking about how to adapt and employ cytokines, messenger molecules of the blood and immune system, as tools for treatment and the promise of precision medicine.
-
Campus & Community
Steven Hyman awarded 2016 Sarnat Prize
The National Institute of Mental Health has awarded Professor Steven Hyman ’80 the 2016 Sarnat Prize for his work on treating and understanding psychiatric disorders as biological diseases.
-
Science & Tech
On demand, and now on schedule
Joshua Meier ’18, a computer science and chemistry concentrator at the Harvard John A. Paulson School of Engineering and Applied Sciences, launched TaxiLater, an iPhone app that lets users arrange an Uber pickup hours, days, or even months in advance.
-
Campus & Community
Two professors win Wolf Prize
Harvard professors C. Ronald Kahn and Stuart L. Schreiber have won the Wolf Prize, considered the most prestigious award in science after the Nobel Prize and the Lasker Award.
-
Health
Neurons reprogrammed in animals
Harvard Stem Cell Institute researchers have shown that the networks of communication among reprogrammed neurons and their neighbors in the brains of living animals can also be changed, or “rewired.”
-
Health
‘Achilles’ heel’ of sickle cell disease?
Gene-editing study reveals pathway that could help short circuit sickle cell disease.